DNAAF5 and hepatocellular carcinoma: USP39 is recruited by dynein axonemal assembly factor 5 (DNAAF5), and stabilize phosphofructokinase L (PFKL) through the deubiquitination pathway, thereby promoting HCC proliferation and resistance to sorafenib150.